| What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry S Wagner, S Wakeman Research Policy 45 (5), 1091-1102, 2016 | 120 | 2016 |
| Innovation in multi-invention contexts: Mapping solutions to technological and intellectual property complexity D Somaya, D Teece, S Wakeman California Management Review 53 (4), 47-79, 2011 | 110 | 2011 |
| Technology commercialization strategy in a dynamic context: Developing specialized complementary assets in entrepreneurial firms DH Hsu, SD Wakeman ESMT Working Paper, 2013 | 32* | 2013 |
| An economic assessment of the relationship between price regulation and incentives to innovate in the pharmaceutical industry H Friederiszick, N Tosini, F De Véricourt, S Wakeman European School of Management and Technology, 2009 | 13 | 2009 |
| Innovation and the performance of New Zealand firms S Wakeman, P Conway New Zealand Productivity Commission, Te Kōmihana Whai Hua o Aotearoa, 2017 | 12 | 2017 |
| Measuring the innovative activity of New Zealand firms S Wakeman, T Le New Zealand Productivity Commission Working Paper 2, 2015 | 8 | 2015 |
| Business models and patent strategies in multi-invention contexts D Somaya, D Teece, S Wakeman Ivey Business Journal 76 (5), 9-11, 2012 | 6 | 2012 |
| Contracting and intellectual property issues in biotech commercialization strategy SD Wakeman University of California, Berkeley, 2007 | 6 | 2007 |
| How does obtaining intellectual property rights impact technology commercialization strategy for start-up innovators? Reconciling the effects on licensing vs. financing SD Wakeman ESMT Working Paper, 2012 | 5* | 2012 |
| The Impact of R & D Grants on the Performance of New Zealand Firms S Wakeman New Zealand Productivity Commission, Te Kōmihana Whai Hua o Aotearoa, 2016 | 3 | 2016 |
| What do patent-based measures tell us about product commercialization S Wagner, S Wakeman Evidence from the pharmaceutical industry, ESMT, 2015 | 3 | 2015 |
| The experience of New Zealand companies in commercializing innovation internationally: Summary of findings from interviews with company executives SD Wakeman ESMT White Paper, 2013 | | 2013 |
| The Process of Negotiating Interfirm Collaborations to Develop Technological Innovations: Report on a Research Study of Australian Life Sciences Firms S Wakeman University of California, Berkeley, 2005 | | 2005 |
| Bargaining for Interconnection in a Light-Handed Regulatory Regime S Wakeman | | 2003 |
| A Law and Economics Analysis of Medical Negligence Law in New Zealand: A Dissertation Submitted in Partial Fulfilment of the Requirements of the Degree of Bachelor of Laws … SD Wakeman University of Otago, 1996 | | 1996 |
Stefan WagnerESMT BerlinVerified email at esmt.org
